1. Contractors
  2. Hemoglobin Oxygen Therapeutics LLC

Hemoglobin Oxygen Therapeutics LLC

Federal contractor · Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Hemoglobin Oxygen Therapeutics has 1 federal contract of $100,000 or more active since October 2023, with $9.56M obligated, from 1 agency. 1 is still running.

Contracts
1 since FY2024$9,559,948 obligated, contracts of $100,000 or more
Running now
1 contract
Biggest customer
Defense Health Agency$9.56M on 1 contract
UEI
UJAMF5FC81N9Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Running contracts

Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.

ContractObligatedEndsState
Canine Oxygen Carrier Manufacturing Restoration and Regulatory ActivitiesDefense Health Agency · HT942525C0035$9,559,948May 31, 2029in 30 monthsPA

End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.

Who they work for

AgencyAmount
Defense Health Agency1 contract$9,559,948

Where the work is

Place of workAmount
Pennsylvania1 contract$9,559,948

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Defense Health Agency: see the list.

Get new notices like Hemoglobin Oxygen Therapeutics's work

New contract opportunities under NAICS 541715, research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology), the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy